BetterLife Pharma (BETRF) EBT (2015 - 2022)
BetterLife Pharma (BETRF) posted quarterly EBT of -$2.4 million for Q2 2022, down 25.8% year-over-year from -$3.2 million in Q2 2021, and up 23.11% quarter-over-quarter from -$3.1 million in Q1 2022.
BetterLife Pharma (BETRF) EBT (2015 - 2022) Analysis & Trends
BetterLife Pharma's EBT history runs 8 years deep, the most recent figure standing at -$2.4 million for Q2 2022.
- In Q2 2022, EBT fell 25.8% year-over-year to -$2.4 million; the TTM figure through Apr 2022 stood at -$10.1 million (up 66.27% YoY), while the FY2026 annual figure was -$1.1 million, up 56.56% from the prior year.
- EBT for Q2 2022 stood at -$2.4 million, up from -$3.1 million in the prior quarter.
- The five-year high for EBT was $463395.5 in Q1 2018, with the low at -$21.2 million in Q1 2021.
- The 5-year median for EBT is -$2.0 million (2018), against an average of -$3.4 million.
- The sharpest annual moves came in 2018 and 2021: EBT jumped 155.82% in 2018, then tumbled 20655.48% in 2021.
- BetterLife Pharma's EBT stood at -$1.5 million in 2018, then sank by 34.76% to -$2.1 million in 2019, then tumbled by 170.89% to -$5.6 million in 2020, then soared by 68.96% to -$1.8 million in 2021, then tumbled by 34.54% to -$2.4 million in 2022.
- Business Quant data shows BETRF's EBT at -$2.4 million in Q2 2022, -$3.1 million in Q1 2022, and -$1.8 million in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | BetterLife Pharma | 40.15 Mn | 42.53 Mn | - | -418,546.79 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2022 | -2.36 Mn |
| Jan 31, 2022 | -3.07 Mn |
| Oct 31, 2021 | -1.75 Mn |
| Jul 31, 2021 | -2.91 Mn |
| Apr 30, 2021 | -1.87 Mn |
| Jan 31, 2021 | -21.23 Mn |
| Oct 31, 2020 | -5.65 Mn |
| Jul 31, 2020 | -1.15 Mn |
| Apr 30, 2020 | -9,030.52 |
| Apr 30, 2019 | -2.08 Mn |
| Oct 31, 2018 | -1.55 Mn |
| Jul 31, 2018 | -1.90 Mn |
| Apr 30, 2018 | -2.37 Mn |
| Jan 31, 2018 | 463,395.50 |
| Jul 31, 2017 | -257,120.00 |
| Apr 30, 2017 | -294,307.00 |
| Jan 31, 2017 | -830,187.00 |
| Oct 31, 2016 | -693,916.00 |
| Jul 31, 2016 | -1.18 Mn |
| Apr 30, 2016 | -3.33 Mn |